Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Panelists discuss how immunoglobulin A (IgA) nephropathy treatment has evolved to include supportive care with optimized blood pressure control and renin-angiotensin system blockade as first-line ...